Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.52 |
| ▸ | ACP3 | P15309 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.38 |
| ▸ | ACACA | Q13085 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6380712 | 0.93 | SRC (0.73) | SRCPTGS2ACP3CYP2D6LMNA | |
| SCHEMBL271988 | 0.91 | SRC (0.78) | SRCPTGS2CYP2D6LMNAMAPK1 | |
| SCHEMBL3539998 | 0.89 | SRC (0.54) | SRCPTGS2 | |
| SCHEMBL1657158 | 0.82 | SRC (0.58) | SRCPTGS2ACP3CYP1A2GAA | |
| SCHEMBL3540946 | 0.82 | POLB (0.54) | SRCMAPK1 | |
| SCHEMBL7754587 | 0.81 | SRC (0.64) | SRCCYP2D6LMNACYP1A2GAA | |
| SCHEMBL6187748 | 0.80 | PTGS2 (0.60) | SRCPTGS2ACP3ACACBACACA | |
| SCHEMBL148725 | 0.80 | SRC (1.00) | SRCCYP2D6LMNAMAPK1CYP1A2 | |
| SCHEMBL70165 | 0.80 | SRC (1.00) | SRCCYP2D6LMNAMAPK1CYP1A2 | |
| SCHEMBL9494308 | 0.79 | SRC (0.61) | SRCPTGS2CYP2D6LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2397504-A1 | (METH)ACRYLATE COMPOUND CONTAINING AROMATIC GROUP | Showa Denko K.K. (JP) | 2011-12-21 | — | — | EP | disclosed |
| US-20110294948-A1 | AROMATIC GROUP-CONTAINING (METH) ACRYLATE COMPOUND | SHOWA DENKO K.K. (JP) | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294948-A1 | AROMATIC GROUP-CONTAINING (METH) ACRYLATE COMPOUND | ACR, MMAB, ATR | SRC 2440/4885PTGS2 2959/4885ACP3 4518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.